Cyp Substrates + Linvoseltamab Gcpt Interaction
Moderateinteraction on record
Description
Linvoseltamab-gcpt causes cytokine release that may suppress CYP enzyme activity, increasing CYP substrate exposure and risk of adverse reactions. Monitoring for toxicity recommended.
Mechanism
Cytokine-mediated suppression of cytochrome P450 enzyme activity
Source: NLP:linvoseltamab-gcpt